Adaptive Biotechnologies - Stock Price History | ADPT

Historical daily share price chart and data for Adaptive Biotechnologies since 2021 adjusted for splits. The latest closing stock price for Adaptive Biotechnologies as of September 27, 2021 is 35.83.
  • The all-time high Adaptive Biotechnologies stock closing price was 67.74 on January 22, 2021.
  • The Adaptive Biotechnologies 52-week high stock price is 71.25, which is 98.9% above the current share price.
  • The Adaptive Biotechnologies 52-week low stock price is 29.73, which is 17% below the current share price.
  • The average Adaptive Biotechnologies stock price for the last 52 weeks is 45.26.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Adaptive Biotechnologies Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 39.5903 29.3700 65.4700 16.9600 59.1300 97.63%
2019 34.9107 40.3000 53.5100 24.5600 29.9200 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.044B $0.098B
Adaptive Biotechnologies Corporation is a commercial-stage biotech company. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of disease. The company's product pipeline includes immunoSEQ, clonoSEQ and cellular therapy which are in clinical stage. Adaptive Biotechnologies Corporation is based in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29